Antifungal resistance, combinations and pipeline: oh my!

Kayla R Stover, Brandon K Hawkins, J Myles Keck, Katie E Barber, David A Cretella

Article Type

Review

Published

The purpose of this review is to discuss resistance mechanisms and challenges with currently available agents, provide evidence for combination therapy, and evaluate the newly available and upcoming antifungal agents and their proposed place in the treatment of challenging fungal infections.

Read more

Tinea pedis: an updated review

Alexander KC Leung, Benjamin Barankin, Joseph M Lam, Kin Fon Leong, Kam Lun Hon

Article Type

Review

Published

This review aims to familiarize physicians with the clinical features, diagnosis and management of tinea pedis.

Read more

Individuals at risk for severe COVID-19 in whom ritonavir-containing therapies are contraindicated or may lead to interactions with concomitant medications: a retrospective analysis of German health insurance claims data

Christoph Lübbert, Igor Dykukha, Jann-Patrick Pelz, Helen Yearley, Wolfgang Junker, Nina Gruber, Sibyll Escher, Katrin Biereth, Sima Melnik, Julia Puschmann

Article Type

Review

Published

This article aimed to assess the prevalence of individuals with one or more risk factors for severe COVID-19 along with contraindications and potential drug–drug interactions due to ritonavir-containing COVID-19 therapy.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.